Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Other Non-Current Liabilities (2020 - 2023)

Historic Other Non-Current Liabilities for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $1.1 million.

  • Terns Pharmaceuticals' Other Non-Current Liabilities rose 5684.06% to $1.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.1 million, marking a year-over-year increase of 5684.06%. This contributed to the annual value of $1.1 million for FY2022, which is 3608.64% up from last year.
  • Per Terns Pharmaceuticals' latest filing, its Other Non-Current Liabilities stood at $1.1 million for Q3 2023, which was up 5684.06% from $1.1 million recorded in Q2 2023.
  • Terns Pharmaceuticals' 5-year Other Non-Current Liabilities high stood at $1.1 million for Q3 2023, and its period low was $654000.0 during Q1 2021.
  • Over the past 4 years, Terns Pharmaceuticals' median Other Non-Current Liabilities value was $768000.0 (recorded in 2021), while the average stood at $837416.7.
  • As far as peak fluctuations go, Terns Pharmaceuticals' Other Non-Current Liabilities surged by 661.65% in 2022, and later surged by 5684.06% in 2023.
  • Terns Pharmaceuticals' Other Non-Current Liabilities (Quarter) stood at $657000.0 in 2020, then grew by 19.79% to $787000.0 in 2021, then skyrocketed by 36.09% to $1.1 million in 2022, then increased by 3.83% to $1.1 million in 2023.
  • Its Other Non-Current Liabilities was $1.1 million in Q3 2023, compared to $1.1 million in Q2 2023 and $1.1 million in Q1 2023.